A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer
1 other identifier
interventional
500
1 country
1
Brief Summary
The purpose of this study is to establish the effects of VATS lobectomy for early-stage non-small cell lung cancer. The aims of this study are:
- 1.To evaluate the early clinical benefits of VATS lobectomy when compared with the axillary thoracotomy.
- 2.To evaluate the late effects of VATS lobectomy on survival and quality of life when compared with axillary thoracotomy.
- 3.To establish the normative pattern of VATS lobectomy for early-stage non-small cell lung cancer.
- 4.To explore the indication of VATS lobectomy for the lung cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable nonsmall-cell-lung-cancer
Started Jan 2010
Longer than P75 for not_applicable nonsmall-cell-lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 6, 2010
CompletedFirst Posted
Study publicly available on registry
April 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFebruary 28, 2018
February 1, 2018
8.9 years
April 6, 2010
February 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease-free survival and overall survival
5 years
Secondary Outcomes (6)
Quality of life
the first year after the surgery
Postoperative pulmonary function
the first three months after the surgery
Postoperative Karnofsky performance status
the first year after the surgery
Postoperative Chest Pain
the first year after the surgery
Perioperation data
perioperation
- +1 more secondary outcomes
Study Arms (2)
VATS group
EXPERIMENTALvideo-assisted thoracoscopic surgery
axillary thoracotomy
OTHERControl group
Interventions
Eligibility Criteria
You may qualify if:
- Early stage NSCLC and no metastasis of hilum of lung and mediastinum lymph nodes (short diameter ≤ 1 cm) on computed tomography (CT) scan;
- No medical contraindications to lung resection
- Age ≤ 75 years old and ≥18 years old;
- Sign the informed consent form.
You may not qualify if:
- Evidence of invasion into neighboring organs;
- Extensive pleura adhesion;
- Central lesion;
- Not suitable for single-lung ventilation;
- Had history of thoracotomy and radiation for thoracic region ;
- Pregnancy or lactation female patients;
- Cannot sign the informed consent form because of psychological, family and society factors;
- Had history of other malignant tumors within 5 years except for non-melanoma cutaneous cancer, uterine cervix cancer in situ and curative early-stage carcinoma of prostate;
- Participants can not accept operation for other uncontrolled factors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Related Publications (2)
1.Bethencourt DM, Holmes EC. Muscle-sparing posterolateral thoracotomy. Ann Thorac Surg. 1988;45(3):337-339. 2.Ginsberg RJ. Alternative (muscle-sparing) incisions in thoracic surgery. Ann Thorac Surg. 1993;56(3):752-754. 3.Weissberg D, Kaufman M. Technical aids in surgery. Two muscle-sparing thoracotomies--techniques and indications. S Afr J Surg. 1990;28(1):17-19. 4.Akçali Y, Demir H, Tezcan B. The effect of standard posterolateral versus muscle-sparing thoracotomy on multiple parameters. Ann Thorac Surg. 2003;76(4):1050-1054. 5.Hazelrigg SR, Landreneau RJ, Boley TM, et al. The effect of muscle-sparing versus standard posterolateral thoracotomy on pulmonary function, muscle strength, and postoperative pain. J Thorac Cardiovasc Surg. 1991;101(3):394-400. 6.Kutlu CA, Akin H, Olcmen A, et al. Shoulder-girdle strength after standard and lateral muscle-sparing thoracotomy. Thorac Cardiovasc Surg. 2001;49(2):112-114. 7.Khan IH, McManus KG, McCraith A, et al. Muscle sparing thoracotomy: a biomechanical analysis confirms preservation of muscle strength but no improvement in wound discomfort. Eur J Cardiothorac Surg. 2000;18(6):656-661. 8.Baeza OR, Foster ED. Vertical axillary thoracotomy: a functional and cosmetically appealing incision. Ann Thorac Surg. 1976;22(3):287-288.
BACKGROUNDLong H, Tan Q, Luo Q, Wang Z, Jiang G, Situ D, Lin Y, Su X, Liu Q, Rong T. Thoracoscopic Surgery Versus Thoracotomy for Lung Cancer: Short-Term Outcomes of a Randomized Trial. Ann Thorac Surg. 2018 Feb;105(2):386-392. doi: 10.1016/j.athoracsur.2017.08.045. Epub 2017 Dec 2.
PMID: 29198623DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hao Long, professor
Sun Yat-sen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sun Yat-sen University Cancer Center
Study Record Dates
First Submitted
April 6, 2010
First Posted
April 13, 2010
Study Start
January 1, 2010
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
February 28, 2018
Record last verified: 2018-02